| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.020 | 15.913 | 9.858 | 16.115 | 14.714 | 10.175 | 35.251 | 19.038 | 11.162 | 8.484 |
| Total Income - EUR | 15.020 | 15.913 | 9.858 | 16.117 | 14.715 | 10.175 | 35.252 | 19.052 | 11.162 | 8.485 |
| Total Expenses - EUR | 4.510 | 4.179 | 2.030 | 2.366 | 2.719 | 1.324 | 23.629 | 7.105 | 5.451 | 5.709 |
| Gross Profit/Loss - EUR | 10.511 | 11.734 | 7.828 | 13.751 | 11.996 | 8.851 | 11.624 | 11.947 | 5.711 | 2.776 |
| Net Profit/Loss - EUR | 10.061 | 11.248 | 7.528 | 13.267 | 11.555 | 8.546 | 11.276 | 11.477 | 4.817 | 2.339 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
Check the financial reports for the company - Igmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 |
| Current Assets | 10.691 | 11.725 | 8.023 | 15.011 | 13.340 | 10.256 | 13.261 | 13.222 | 5.152 | 7.878 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 143 | 687 | 1.316 | 812 | 928 | 0 | 235 | 476 |
| Cash | 10.691 | 11.725 | 7.880 | 14.324 | 12.024 | 9.443 | 12.333 | 13.222 | 4.918 | 7.402 |
| Shareholders Funds | 10.106 | 11.293 | 7.572 | 13.310 | 11.597 | 8.587 | 11.317 | 11.517 | 4.857 | 7.169 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 584 | 432 | 451 | 1.701 | 1.743 | 1.669 | 1.944 | 1.705 | 295 | 717 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Igmed Srl